Tanhaji, Sarenah A.
HRN: 23-64-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2023
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
09/04/2023
09/10/2023
PO
5 Ml
BID
Ascariasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes